Evidence map›Paper›PMID 24265648›Full record

ArticleClinical practice and epidemiology in mental health : CP & EMH2013

The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate.

Hanna Edebol, Lars Helldin, Torsten Norlander

2 registry-linked trialsAbstract read
In one paragraph

Article in Clinical practice and epidemiology in mental health : CP & EMH, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02473185 phase4completednot on this mapstarted 2015, after this paper: background citation

Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD

TypeinterventionalSponsorRegion VästmanlandRan2015 to 2018Enrolled40ConditionsAttention Deficit Hyperactivity DisorderArmsMethylphenidate
NCT02477280 phase4completednot on this mapstarted 2016, after this paper: background citation

Effects of Expectation, Medication and Placebo on Objective and Self-rated Performance During the Quantified Behavior Test in Patients With Untreated ADHD and Substance Use Disorder

TypeinterventionalSponsorRegion VästmanlandRan2016 to 2021Enrolled39ConditionsAttention Deficit Hyperactivity Disorder, Substance Use DisorderArmsMethylphenidate, Placebo
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. QbTest for Monitoring Medication Treatment Response in ADHD: A Systematic Review.Clinical practice and epidemiology in mental health : CP & EMH · 2023
    Pooled it
  2. Normative Data for Objective ADHD Smartphone Application in a General Population.Clinical practice and epidemiology in mental health : CP & EMH · 2025
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hanna EdebolNutrition Gut Brain Interactions Research Centre, Örebro University, Örebro, Sweden.
Lars Helldin
Torsten Norlander

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTwo measures of the response rate and the optimal treatment response for adult ADHD were evaluated using methylphenidate. The hypotheses were that Prediction of ADHD (PADHD) defines remission, the Weighed Core Symptom (WCS) scale registers direct effects of medication and that WCS may indicate the optimal dose level during titration.

designPADHD and WCS were analyzed at baseline and after intake of low doses of either short-acting or modified-release formulations of methylphenidate, MPH (Study I), during titration with modified-release formulations of MPH (18/27, 36, 54, 72 mg) and at three months follow-up (Study II). PATIENTS: Study I consisted of 63 participants (32 females) and Study II consisted of 10 participants (6 females) diagnosed with ADHD and who was to start with treatment. OUTCOME MEASURES: Prediction of ADHD (PADHD) indicates the occurrence of ADHD (No, Yes) and the Weighed Core Symptom scale (WCS) quantifies ADHD from 0 to 100 (max-min).

resultsThe number of clinical cases of ADHD decreased after methylphenidate treatment according to PADHD. WCS increased (p < 0.001) from 9.75 (SD = 12.27) to 47.50 (SD = 29.75) with about 10 mg of methylphenidate (N = 63). During titration, symptoms improved after 18/27 mg and 36 mg of methylphenidate and baseline-follow up comparisons showed WCS increments (p = 0.005) from 31.00 (N = 10, SD = 26.85) to 69.00 (N = 10, SD = 22.34).

conclusionsPADHD defined remission and WCS measured therapeutic effects of methylphenidate in adult ADHD.

Indexed as

ADHD.Objective measuresPrediction of ADHDremissionWeighed Core Symptom scale

Identifiers

PMID24265648
PMCPMC3821084

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.